Deltex Medical develops and markets hemodynamic monitoring systems to measure blood flow and pressure in the central circulation.Read more
Deltex Medical's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 567.5M. Over the last two quarters, Deltex Medical's revenue has decreased by 0%. Specifically, in Q4 2020's revenue was $3.3M; in Q3 2020, it was $3.3M.
No recent acquisitions found related to Deltex Medical
No recent investments found related to Deltex Medical